145 related articles for article (PubMed ID: 11919179)
1. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.
Nisole S; Said EA; Mische C; Prevost MC; Krust B; Bouvet P; Bianco A; Briand JP; Hovanessian AG
J Biol Chem; 2002 Jun; 277(23):20877-86. PubMed ID: 11919179
[TBL] [Abstract][Full Text] [Related]
2. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.
Nisole S; Krust B; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG
J Biol Chem; 1999 Sep; 274(39):27875-84. PubMed ID: 10488134
[TBL] [Abstract][Full Text] [Related]
3. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor.
Said EA; Krust B; Nisole S; Svab J; Briand JP; Hovanessian AG
J Biol Chem; 2002 Oct; 277(40):37492-502. PubMed ID: 12147681
[TBL] [Abstract][Full Text] [Related]
4. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin.
Hovanessian AG
Cell Res; 2006 Feb; 16(2):174-81. PubMed ID: 16474431
[TBL] [Abstract][Full Text] [Related]
5. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells.
Legrand D; Vigié K; Said EA; Elass E; Masson M; Slomianny MC; Carpentier M; Briand JP; Mazurier J; Hovanessian AG
Eur J Biochem; 2004 Jan; 271(2):303-17. PubMed ID: 14717698
[TBL] [Abstract][Full Text] [Related]
6. The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin.
Krust B; Vienet R; Cardona A; Rougeot C; Jacotot E; Callebaut C; Guichard G; Briand JP; Grognet JM; Hovanessian AG; Edelman L
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14090-5. PubMed ID: 11698640
[TBL] [Abstract][Full Text] [Related]
7. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin.
Said EA; Courty J; Svab J; Delbé J; Krust B; Hovanessian AG
FEBS J; 2005 Sep; 272(18):4646-59. PubMed ID: 16156786
[TBL] [Abstract][Full Text] [Related]
8. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.
Krust B; El Khoury D; Nondier I; Soundaramourty C; Hovanessian AG
BMC Cancer; 2011 Aug; 11():333. PubMed ID: 21812966
[TBL] [Abstract][Full Text] [Related]
9. The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells.
Nisole S; Krust B; Dam E; Bianco A; Seddiki N; Loaec S; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):237-49. PubMed ID: 10710212
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.
Fujiki H; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2014 May; 140(5):689-99. PubMed ID: 24469254
[TBL] [Abstract][Full Text] [Related]
11. Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain.
Pellar GJ; DiMario PJ
Chromosoma; 2003 Apr; 111(7):461-9. PubMed ID: 12707784
[TBL] [Abstract][Full Text] [Related]
12. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains.
Nisole S; Krust B; Hovanessian AG
Exp Cell Res; 2002 Jun; 276(2):155-73. PubMed ID: 12027446
[TBL] [Abstract][Full Text] [Related]
13. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A
BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.
Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG
Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin.
Destouches D; El Khoury D; Hamma-Kourbali Y; Krust B; Albanese P; Katsoris P; Guichard G; Briand JP; Courty J; Hovanessian AG
PLoS One; 2008 Jun; 3(6):e2518. PubMed ID: 18560571
[TBL] [Abstract][Full Text] [Related]
16. Two RNA-binding domains determine the RNA-binding specificity of nucleolin.
Serin G; Joseph G; Ghisolfi L; Bauzan M; Erard M; Amalric F; Bouvet P
J Biol Chem; 1997 May; 272(20):13109-16. PubMed ID: 9148924
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV infection by the cytokine midkine.
Callebaut C; Nisole S; Briand JP; Krust B; Hovanessian AG
Virology; 2001 Mar; 281(2):248-64. PubMed ID: 11277697
[TBL] [Abstract][Full Text] [Related]
18. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
19. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
Ueno T; Tokunaga K; Sawa H; Maeda M; Chiba J; Kojima A; Hasegawa H; Shoya Y; Sata T; Kurata T; Takahashi H
Microbiol Immunol; 2004; 48(2):111-8. PubMed ID: 14978336
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA.
Ghisolfi-Nieto L; Joseph G; Puvion-Dutilleul F; Amalric F; Bouvet P
J Mol Biol; 1996 Jul; 260(1):34-53. PubMed ID: 8676391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
